Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

94 Press Releases
DateTitleCompany
24 Feb 15 New study indicates lower dose of Advagraf is significantly beneficial for transplant patients Astellas
24 Feb 15 DIAMOND (ADVAGRAF Studied in Combination With Mycophenolate Mofetil (MMF) and Basiliximabin Liver Transplantation) Study Provides Insights Into Kidney Function and the Prophylaxis of Organ Rejection in Liver Transplant Patients Astellas Pharma,
Published by
PR Newswire
02 Feb 15 Astellas Broadens Commitment to Clinical Trial Data Transparency ASTELLAS PHARMA INC.,
Published by
PR Newswire
27 Jan 15 ASTELLAS EUROPEAN FOUNDATION TRANSPLANTATION GRANT AWARDED TO DR NIEUWENHUIJS-MOEKE TO IMPROVE THE OUTCOME OF ORGAN TRANSPLANTATION BY ADVANCING ANAESTHESIOLOGICAL CARE ASTELLAS,
Published by
PharmiWeb.com
27 Jan 15 ASTELLAS EUROPEAN FOUNDATION TRANSPLANTATION GRANT AWARDED TO DR NIEUWENHUIJS-MOEKE TO IMPROVE THE OUTCOME OF ORGAN TRANSPLANTATION BY ADVANCING ANAESTHESIOLOGICAL CARE Astellas
27 Jan 15 ASTELLAS EUROPEAN FOUNDATION TRANSPLANTATION GRANT AWARDED TO DR NIEUWENHUIJS-MOEKE TO IMPROVE THE OUTCOME OF ORGAN TRANSPLANTATION BY ADVANCING ANAESTHESIOLOGICAL CARE Astellas
27 Jan 15 HEALTH DATA MAY NOT MAKE YOUR BOSS ‘APP-Y THE ASTELLAS INNOVATION DEBATE
25 Jan 15 Astellas European Foundation Transplantation Grant Awarded to Dr Nieuwenhuijs-Moeke to Improve the Outcome of Organ Transplantation by Advancing Anaesthesiological Care The Astellas European Foundation,
Published by
PR Newswire
18 Dec 14 Astellas to Present at J.P. Morgan Healthcare Conference ASTELLAS PHARMA INC.,
Published by
PR Newswire
11 Dec 14 Astellas Named on FTSE4Good Index for the Third Yea Astellas Pharma EMEA
02 Dec 14 XTANDI™ (enzalutamide) Now Approved in Europe for the Treatment of Men with Metastatic Castration-Resistant Prostate Cancer Who Are Chemotherapy-Naïve Astellas Pharma,
Published by
Business Wire
27 Nov 14 UK’S MOST INNOVATIVE SCHOOL STUDENTS AWARDED FOR MOBILE HEALTH APP IDEAS TO BOOST HEALTHY LIVING Astellas Pharma EMEA
04 Nov 14 CHANGING TOMORROWTM DAY 2014 MARKS ASTELLAS’ FIFTH YEAR OF VOLUNTEERING Astellas Pharma EMEA
24 Oct 14 XTANDI™ (Enzalutamide) Capsules Receive Positive CHMP Opinion for the Treatment of Men with Metastatic Castration-Resistant Prostate Cancer Who Are Chemotherapy-Naïve Astellas Pharma,
Published by
Business Wire
29 Sep 14 ASTELLAS EUROPEAN FOUNDATION GRANT AWARDED TO DR GABRIEL VAN DER PLUIJM FOR PROJECT TO DEVELOP A NOVEL TREATMENT FOR CLINICAL USE IN BLADDER CANCER Astellas
28 Sep 14 Astellas European Foundation Grant Awarded to Dr Gabriel Van Der Pluijm for Project to Develop a Novel Treatment for Clinical Use in Bladder Cancer Astellas European Foundation,
Published by
PR Newswire
12 Sep 14 KIDS GET APPETITE FOR APP DEVELOPMENT WITH LAUNCH OF NEW STEM COMPETITION Astellas,
Published by
PharmiWeb.com
08 Sep 14 DIFICLIRTM (fidaxomicin) is more cost effective than current standard of care in cancer patients, a vulnerable population at high risk of clostridium difficile infection Astellas Pharma EMEA
11 Aug 14 ASTELLAS PHARMA EMEA ANNOUNCES NEW SENIOR APPOINTMENTS Astellas Pharma EMEA
08 Aug 14 Cancer Research UK and Cancer Research Technology Join Forces with Astellas on Autophagy to Find New Cancer Treatments ASTELLAS PHARMA INC.,
Published by
PR Newswire
09 Jul 14 Astellas Submits U.S. New Drug Application for Isavuconazole for the Treatment of Invasive Aspergillosis and Invasive Mucormycosis ASTELLAS PHARMA INC.,
Published by
PR Newswire
22 May 14 ASTELLAS ANNOUNCES GROUNDBREAKING €1.5m PROGRAMME TO TACKLE OBSTETRIC FISTULA IN KENYA Astellas Pharma Europe,
Published by
Forster comms
16 Apr 14 Astellas US Promotes Jeffrey Bloss to SVP of Medical Affairs for the Americas ASTELLAS PHARMA INC.,
Published by
PR Newswire
07 Apr 14 ASTELLAS ANNOUNCES MARKETING AUTHORISATION APPLICATION FOR XTANDI™ (ENZALUTAMIDE) FOR CHEMOTHERAPY-NAÏVE METASTATIC PROSTATE CANCER Astellas Pharma Inc
18 Mar 14 FIRST PATIENTS ENROLLED INTO EUROPEAN PHASE III PROGRAMME FOR POTENTIAL FIRST IN CLASS ORAL TREATMENT FOR ANAEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE (CKD) Astellas Pharma Europe Ltd.
24 Sep 13 POST HOC ANALYSIS SUGGESTS THAT BETMIGA™ MAY RELIEVE OVERACTIVE BLADDER SYMPTOMS WHERE PRIOR ANTIMUSCARINIC TREATMENT HAS FAILED Astellas Pharma Europe Ltd.,
Published by
Astellas Pharma Europe Ltd
01 Aug 13 Astellas and FibroGen Announce the Initiation of a Phase 2 Clinical Study in Japan of ASP1517/FG-4592 for Treatment of Anemia of Chronic Kidney Disease Astellas,
Published by
Pharmiweb.com
11 Jul 13 New treatment for the management of advanced prostate cancer Astellas,
Published by
PharmiWeb.com
24 Jun 13 XTANDI™? (ENZALUTAMIDE) AUTHORISED IN THE EUROPEAN UNION (EU) FOR ADVANCED PROSTATE CANCER Astellas Pharma Europe Ltd
24 May 13 Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan Astellas Pharma Inc.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.